Axonics® announces appointment of david m. demski to board of directors

Irvine, calif.--(business wire)--axonics modulation technologies, inc. (nasdaq: axnx), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (snm) devices for the treatment of urinary and bowel dysfunction, today announced the appointment of veteran medical technology industry executive david m. demski to its board of directors, effective january 1, 2021. mr. demski currently serves as president and ceo of globus medical, inc. (nasdaq: g
AXNX Ratings Summary
AXNX Quant Ranking